Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
35.18
-1.89 (-5.10%)
May 18, 2026, 4:00 PM EDT - Market closed
Rapport Therapeutics Employees
Rapport Therapeutics had 84 employees as of December 31, 2025. The number of employees increased by 15 or 21.74% compared to the previous year.
Employees
84
Change (1Y)
15
Growth (1Y)
21.74%
Revenue / Employee
$238,095
Profits / Employee
-$1,277,107
Market Cap
1.68B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 84 | 15 | 21.74% |
| Dec 31, 2024 | 69 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 605 |
| Lakefront Biotherapeutics NV | 558 |
| Syndax Pharmaceuticals | 298 |
| Harmony Biosciences Holdings | 293 |
| Zymeworks | 264 |
| Viridian Therapeutics | 252 |
| uniQure | 221 |
| AnaptysBio | 104 |
RAPP News
- 11 days ago - Rapport Therapeutics reports Q1 EPS (42c), consensus (71c) - TheFly
- 12 days ago - Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update - GlobeNewsWire
- 18 days ago - Modalités de mise à disposition du rapport financier annuel 2025 - GlobeNewsWire
- 18 days ago - MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 - GlobeNewsWire
- 27 days ago - Rapport Therapeutics presents results from Phase 2a trial of RAP-219 - TheFly
- 27 days ago - Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting - GlobeNewsWire
- 5 weeks ago - Rapport Therapeutics initiated with a Strong Buy at Raymond James - TheFly
- 5 weeks ago - Rapport Therapeutics initiated with a Strong Buy at Raymond James - TheFly